采用交联人脱细胞真皮基质预防和解决二次鼻整形中硅胶假体相关问题
本研究前瞻性纳入2015年1月至2018年12月间在同一诊所行二次鼻整形的104例患者中的56例,随访至少1年,术中均取出硅胶假体、包膜及瘢痕组织,采用交联人脱细胞真皮基质(ADM)行鼻背增高并用自体软骨行鼻尖整形。术后1例感染、3例过度吸收,改良鼻整形结果评估评分术前31.7、术后6个月77.3、术后1年81.4(平均差值分别为45.6和49.7,P < 0.001)。作者认为该方法可成功解决硅胶假体初次鼻整形后的多种问题。
要点
- 56例二次鼻整形患者采用交联人ADM行鼻背增高并自体软骨鼻尖整形,随访至少1年。
- 术后1例感染、3例过度吸收,无其他主要并发症。
- 改良鼻整形结果评估评分术前31.7、术后6个月77.3、术后1年81.4(P < 0.001)。
核心结论
- 作者认为,采用交联人ADM行鼻背增高联合自体软骨鼻尖整形行二次鼻整形,可成功解决硅胶假体初次鼻整形后的多种问题,手术结果在挛缩畸形改善、低感染率、假体固定牢固、皮肤软组织覆盖质地与厚度良好以及获得理想高度和鼻背线条方面表现良好。
研究设计与样本
- 前瞻性研究,纳入2015年1月至2018年12月间在同一诊所行二次鼻整形的104例患者中的56例,随访至少1年。
- 所有患者均行硅胶假体、包膜及瘢痕组织取出,采用交联人ADM行鼻背增高,并用自体软骨行鼻尖整形。
- 采用改良鼻整形结果评估(10项问卷)于术前、术后6个月及术后1年以上进行评估。
- 证据等级:治疗性,IV级。
主要发现
- 术后1例感染、3例过度吸收,无其他主要并发症。
- 改良鼻整形结果评估平均评分术前为31.7,术后6个月为77.3,术后1年为81.4(平均差值分别为45.6和49.7;P < 0.001)。
关键数值与推荐
- 改良鼻整形结果评估评分术前31.7 vs 术后6个月77.3(平均差值45.6,P < 0.001)。
- 改良鼻整形结果评估评分术前31.7 vs 术后1年81.4(平均差值49.7,P < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Silicone implant augmentation rhinoplasty along with various tip plasties are commonly performed in Asian patients, but a revision rhinoplasty is frequently required because of various problems. Secondary rhinoplasties are often performed using silicone, dermofat, costal cartilage block, or diced rib cartilage, but often result in unsatisfactory outcomes. This study assessed the surgical outcomes and complications of cross-linked acellular dermal matrix (ADM) as an alternative biological substitute for silicone implant in secondary rhinoplasty. METHODS: The authors prospectively studied 56 patients with a minimum follow-up of 1 year among 104 patients who underwent secondary rhinoplasty in their clinic between January of 2015 and December of 2018. Silicone implant, capsule, and scar tissue removal; dorsal augmentation with ADM; and tip plasty using autogenous cartilage were performed for all of them. The results were assessed using the modified Rhinoplasty Outcome Evaluation, consisting of a 10-item questionnaire completed preoperatively, 6 months postoperatively, and over 1 year postoperatively. RESULT: One infection and three cases of excessive resorption were noted, with no other major complications. The mean modified Rhinoplasty Outcome Evaluation score was 31.7 on preoperative evaluation, 77.3 at 6 months postoperatively, and 81.4 at 1 year postoperatively (mean difference, 45.6 and 49.7, respectively; P < 0.001). CONCLUSIONS: Various problems that occur after primary rhinoplasty using silicone implants can be resolved successfully with secondary rhinoplasty by dorsal augmentation using the cross-linked human ADM along with various nasal tip work using autogenous cartilage. Surgical outcome showed favorable resolution of contracture deformities, a low infection rate, firm fixation of the implant, good skin texture/thickness of the skin/soft-tissue envelope, and gain of desired height and dorsal line. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Kook WS, Ryu DH, Baek W, et al. Prevention and Resolution of Silicone Implant-Related Problems in Secondary Rhinoplasty Using a Cross-Linked Human Acellular Dermal Matrix. Plast Reconstr Surg. 2023. PMID: 36728206. doi:10.1097/PRS.0000000000010205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。